Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Effects of lapatinib and trastuzumab on progression free survival

Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA
Effects of lapatinib and trastuzumab on progression free survival ( Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA )
15 Jun 2012

President's overview of ASCO 2012

Dr Michael Link - Stanford School of Medicine, California, USA
President's overview of ASCO 2012 ( Dr Michael Link - Stanford School of Medicine, California, USA )
4 Jun 2012

Afatinib delays progression of advanced lung adenocarcinomas

Dr James Yang - National Taiwan University Hospital, Taipei
Afatinib delays progression of advanced lung adenocarcinomas ( Dr James Yang - National Taiwan University Hospital, Taipei )
4 Jun 2012

Routine molecular testing of non-small cell lung cancers in community settings

Dr Thomas Zander - University Hospital Cologne, Germany
Routine molecular testing of non-small cell lung cancers in community settings ( Dr Thomas Zander - University Hospital Cologne, Germany )
4 Jun 2012

Increased progression-free survival in advanced lung cancer with afatinib

Dr James Yang - National Taiwan University Hospital Taipei, Taiwan
Increased progression-free survival in advanced lung cancer with afatinib  ( Dr James Yang - National Taiwan University Hospital Taipei, Taiwan )
3 Jun 2012

Bendamustine regimen more effective for lymphoma than standard CHOP

Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany
Bendamustine regimen more effective for lymphoma than standard CHOP ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )
3 Jun 2012

Problems in the structure of clinical trials

Prof Thomas Tursz – Institut Gustave Roussy, Paris, France
Problems in the structure of clinical trials ( Prof Thomas Tursz – Institut Gustave Roussy, Paris, France )
21 May 2012

Prognostic biomarkers and next generation genomic sequencing

Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany
Prognostic biomarkers and next generation genomic sequencing ( Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany )
21 May 2012

Use of bio-banks in the EurocanPlatform

Prof Peter Riegman – Erasmus Medical Centre, Rotterdam, Netherlands
Use of bio-banks in the EurocanPlatform ( Prof Peter Riegman – Erasmus Medical Centre, Rotterdam, Netherlands )
18 May 2012

Recent developments in neoadjuvant therapy

Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany
Recent developments in neoadjuvant therapy ( Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany )
17 May 2012

Highlights and goals of IMPAKT 2012

Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium
Highlights and goals of IMPAKT 2012 ( Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium )
17 May 2012

PI3K and the heterogeneity of small tumour breast cancer

Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium
PI3K and the heterogeneity of small tumour breast cancer ( Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium )
17 May 2012